A statement released earlier today by Joh. Berenberg Gossler & Co. KG about Carl Zeiss Meditec (ETR:AFX) bumps the target price to 36.00EUR
- Updated: September 19, 2016
Yesterday Carl Zeiss Meditec (ETR:AFX) traded 0.00% even at 34.45EUR. The company’s 50-day average is 0.00EUR and its two hundred day average is 0.00EUR. With the last stock price close up 0.00% from the two hundred day average, compared to the Standard & Poor’s 500 Index which has fallen -0.01% over the same time. Volume of trade was held steady, with 0 shares of AFX changing hands on par with the typical 0 shares..
In a statement issued on 9/19/2016 Joh. Berenberg Gossler & Co. KG increased the target price of Carl Zeiss Meditec (ETR:AFX) from 0EUR to 36EUR reporting a possible upsideof 0.04%.
Previously on 9/15/2016, Kepler Cheuvreux released a statement for Carl Zeiss Meditec(ETR:AFX) upped the target price from 0.00EUR to 32.00EUR. At the time, this indicated a possible downside of -0.05%.
Recent Performance Graph:
With a total market value of 0.0 EUR, Carl Zeiss Meditec has a one-year low of 0.00EUR and a one-year high of 0.00EUR with a PE ratio of 0.
About Carl Zeiss Meditec (ETR:AFX)
Carl Zeiss Meditec AG is a Germany-based medical technology solutions supplier. The Company operates, along with its subsidiaries, in two business areas: Ophthalmology and Microsurgery. The Ophthalmology business area is subdivided into two business units: the Ophthalmology systems unit covers a range of laser and diagnostic systems for ophthalmology, and the Surgical Ophthalmology unit combines the Company’s activities in the field of ophthalmic implants and disposables. The Microsurgery business area offers surgical microscopes and visualization solutions for ear, nose and throat surgery, or neurosurgery. Its microsurgery products are mainly used as supporting equipment for the removal of tumors, as well as the treatment of vascular diseases and functional disorders. In January 2014, it acquired Optronik Optik ve Elektronik Cihazlar Ticaret ve Sanayi AS, a wholesaler of ophthalmology products, as well as a 100% stake in Aaren Scientific Inc, and a producer of intraocular lenses.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.